Crossmark

Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance

Crossref DOI link: https://doi.org/10.1039/C8NR02700E

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Xiao, Yating

Liu, Jing

Guo, Mengyu

Zhou, Huige

Jin, Jun

Liu, Jiaming

Liu, Ying

Zhang, Zhanjun

Chen, Chunying https://orcid.org/0000-0002-6027-0315
Funding

Funding for this research was provided by:

Ministry of Science and Technology of the People's Republic of China (2016YFA0201600)

National Natural Science Foundation of China (11621505, 11425520)
License Information

Accepted Manuscript valid from 2019-06-12
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Chunying Chen (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 3 April 2018; Accepted 12 June 2018; Accepted Manuscript published 12 June 2018; Advance Article published 26 June 2018; Version of Record published 9 July 2018